IL6 and COVID-19: The pathophysiological mechanism of C3a/C5a in COVID-19 remains ambiguous, but these complement anaphylatoxins are known to stimulate inflammatory cytokine (notably IL-6 and TNF) release from macrophages and other cells expressing C3a/C5a receptors [165].